[MYGN] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
13-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -160.87%
YoY- -132.06%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 164,000 195,100 186,300 215,400 216,600 216,800 202,300 -13.04%
PBT -131,100 -11,400 -22,300 -7,700 3,300 3,600 800 -
Tax -15,900 -3,100 -1,700 -3,400 -3,600 1,000 1,600 -
NP -115,200 -8,300 -20,600 -4,200 6,900 2,600 -700 2893.79%
Tax Rate - - - - 109.09% -27.78% -200.00% -
Total Cost 279,200 203,400 206,900 219,600 209,700 214,200 203,000 23.65%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -70.24 -4.25 -11.06 -1.95 3.19 1.20 -0.35 3316.72%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -1.55 -0.11 -0.28 -0.06 0.09 0.04 -0.01 2776.66%
EPS Diluted -1.55 -0.11 -0.28 -0.06 0.09 0.03 -0.01 2776.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.